Peroxiredoxin 6, a Novel Player in the Pathogenesis of Diabetes
Francesca Pacifici(University of Rome Tor Vergata), Davide Lauro(University of Rome Tor Vergata), David Della‐Morte(Unknown), Roberto Arriga(University of Rome Tor Vergata), Sara Caratelli(National Academies of Sciences, Engineering, and Medicine), Maria Giovanna Scioli(University of Rome Tor Vergata), Gian Pio Sorice(Università Cattolica del Sacro Cuore), Manfredi Tesauro(University of Rome Tor Vergata), Massimo Federici(University of Rome Tor Vergata), Paolo Sbraccia(University of Rome Tor Vergata), Augusto Orlandi(University of Rome Tor Vergata), Donatella Pastore(University of Rome Tor Vergata), Giuseppe Sconocchia(National Academies of Sciences, Engineering, and Medicine), Francesca Ferrelli(University of Rome Tor Vergata), Giulia Donadel(University of Rome Tor Vergata), Barbara Capuani(University of Rome Tor Vergata), Andrea Coppola(University of Rome Tor Vergata), Andrea Giaccari(Università Cattolica del Sacro Cuore), Alfonso Bellia(University of Rome Tor Vergata)
Cited by 113
Related Papers
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
Mandibuloacral Dysplasia Is Caused by a Mutation in LMNA-Encoding Lamin A/C
|The American Journal of Human Genetics|2002|534
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
|Diabetes Care|2019|442
Insulin-Dependent Activation of Endothelial Nitric Oxide Synthase Is Impaired by O-Linked Glycosylation Modification of Signaling Proteins in Human Coronary Endothelial Cells
|Circulation|2002|371
Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
|Journal of Clinical Medicine|2020|252